Nature Biotechnology
Volume 39 Issue 6, June 2021
https://www.nature.com/nbt/volumes/39/issues/6

Editorial | 04 June 2021
Ultra-precision medicine
New initiatives in N-of-1 drug development and clinical trial design offer the possibility of therapies for ultra-rare disease patients who have been long neglected by the drug industry.